Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Schrödinger, Inc.NASDAQ: SDGR

Financing Cash Flow · Q3 FY2026 · quarter ended Sep 2026

Financing cash flow growth accelerates

Q3 FY2026 financing cash flow of $2.72M rose 786.6% year over year, ahead of the +45.0% change in trailing-twelve-month financing cash flow. Sequentially, it rose 318.8% from the prior quarter. Over 3 fiscal years it compounded at +11.6% a year.

Context

  • Financing cash flow amounted to 1.1% of revenue in FY2025, down 3.7 pp from a year earlier.
  • Financing cash flow increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +786.6% holds above the trailing-twelve-month pace of +45.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.72M+318.8% QoQ
Last fiscal yearDec 2025
$2.93M-71.0% YoY
LTMSep 2026
$4.14M+45.0% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+786.6%——
1 year-71.0%——
3-year CAGR+11.6%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
2.93M USD
Year-over-year change
-71.0%
4-year CAGR
-22.1%

Financing Cash Flow vs competitors

How SDGR compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +45.0% is the 6th highest of 9, against a peer median of +110.3%.
  • Financing cash flow amounts to 1.5% of revenue for SDGR, versus a peer median of 22.3%.
SDGR Competitors
Financing Cash Flow for SDGR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VEEVVeeva Systems Inc.LTM Jul 2026$667.24M USD-492.9%-21.6%19.3%
RLAYRelay Therapeutics, Inc.LTM Jun 2026$463.47M USD+110.3%-82.3%4478.0%
ABCLAbCellera Biologics Inc.LTM Sep 2026$225.53M USD+1498.5%—332.4%
CERTCertara, Inc.LTM Mar 2026$93.73M USD+280.1%+105.6%22.3%
GENBGenerate Biomedicines, Inc.FY2025$28.06M USD-69.3%—88.0%
SDGRSchrödinger, Inc.LTM Sep 2026$4.14M USD+45.0%+11.6%1.5%
LTRNLantern Pharma Inc.LTM Mar 2026$1.5M USD+12391.6%——
SLPSimulations Plus, Inc.LTM Feb 2026$590K USD+110.3%-46.8%0.7%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$201.94K CAD-98.8%+72.9%1.1%
Peer median (excluding SDGR) —+110.3%-21.6%22.3%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(101.22M)(149.19M)40.72M(187.12M)(103.27M)
Depreciation & Amortization2.85M4.34M5.55M6.16M6.02M
Deferred Income Tax00000
Stock-Based Compensation26.49M39.63M47.84M49.9M43M
Change in Working Capital4.68M(21.38M)(22.55M)(13.04M)118.17M
Accounts Receivables(5.51M)(27.95M)(20.03M)(166.22M)150.94M
Inventory00000
Accounts Payables(411K)1.18M7.32M(6.12M)908K
Other Working Capital10.6M5.39M(9.85M)159.3M(33.68M)
Other Non-Cash Items(3.46M)6.91M(208.29M)(13.27M)(50.02M)
Operating Cash Flow(70.67M)(119.68M)(136.73M)(157.37M)13.9M
Capital Expenditures(7.17M)(8.01M)(13.4M)(7.31M)(1.44M)
Acquisitions (Net)0(7.03M)(4.13M)45.73M0
Purchases of Investments(418.5M)(271.47M)(320.62M)(251.34M)(312.96M)
Sales of Investments408.48M364.71M383.97M361.76M372.3M
Other Investing Activities375K11.83M147.21M00
Investing Cash Flow(16.81M)90.02M193.03M148.84M57.9M
Debt Repayment00(19K)(58K)(58K)
Common Stock Issued0008.87M2.99M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities7.95M2.11M9.07M1.31M0
Financing Cash Flow7.95M2.11M9.05M10.12M2.93M
Effect of Forex Changes00000
Net Change in Cash(79.53M)(27.55M)65.35M1.59M74.73M
Free Cash Flow(77.84M)(127.7M)(150.14M)(164.68M)12.46M

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.